- Home
- CNSP vs SXTP Comparison
CNSP vs SXTP Comparison
Compare CNSP & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- SXTP
- Stock Information
- Founded
- CNSP 2017
- SXTP 2010
- Country
- CNSP United States
- SXTP United States
- Employees
- CNSP N/A
- SXTP N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CNSP Health Care
- SXTP Health Care
- Exchange
- CNSP Nasdaq
- SXTP Nasdaq
- Market Cap
- CNSP 4.0M
- SXTP 3.7M
- IPO Year
- CNSP 2019
- SXTP 2023
- Fundamental
- Price
- CNSP $6.51
- SXTP $1.00
- Analyst Decision
- CNSP Strong Buy
- SXTP Strong Buy
- Analyst Count
- CNSP 1
- SXTP 3
- Target Price
- CNSP $20.00
- SXTP $4.50
- AVG Volume (30 Days)
- CNSP 18.0K
- SXTP 73.9K
- Earning Date
- CNSP 11-17-2025
- SXTP 11-13-2025
- Dividend Yield
- CNSP N/A
- SXTP N/A
- EPS Growth
- CNSP N/A
- SXTP N/A
- EPS
- CNSP N/A
- SXTP N/A
- Revenue
- CNSP N/A
- SXTP $1,364,945.00
- Revenue This Year
- CNSP N/A
- SXTP $81.41
- Revenue Next Year
- CNSP N/A
- SXTP $83.17
- P/E Ratio
- CNSP N/A
- SXTP N/A
- Revenue Growth
- CNSP N/A
- SXTP 202.10
- 52 Week Low
- CNSP $4.93
- SXTP $0.85
- 52 Week High
- CNSP $114.00
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- CNSP 41.69
- SXTP 31.51
- Support Level
- CNSP $6.04
- SXTP $0.85
- Resistance Level
- CNSP $6.90
- SXTP $1.29
- Average True Range (ATR)
- CNSP 0.57
- SXTP 0.08
- MACD
- CNSP -0.05
- SXTP -0.03
- Stochastic Oscillator
- CNSP 24.29
- SXTP 31.48
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.